- Price:
- $0.76
- Open:
- $0.78
- Previous close:
- $0.76
- Day's range:
- $0.74 - $0.78
- Year's range:
- $0.71 - $8.20
- Net Income per Share:
- -6.81
- Price-to-Earnings ratio:
- -0.11
- 52-week Price Range:
- $1.06
- Volume:
- $833,836.00
- Average volume:
- $1,552,522.00
Company profile for Bionano Genomics, Inc.
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
- Stock exchanges:
- NASDAQ
- Sector:
- Healthcare
- Industries:
- Diagnostics & Research
- Ticker:
- BNGO
- CIK:
- 1411690
- ISIN:
- US09075F1075
- Website:
- https://www.bionanogenomics.com
- Phone:
- 858 888 7600
- Origin:
- United States
- Employees:
- 299